{"title":"Short-range immunity","authors":"Ioana Staicu","doi":"10.1038/s41590-025-02157-z","DOIUrl":null,"url":null,"abstract":"<p>The double-stranded RNA (dsRNA) sensor 2′,5′-oligoadenylate synthetase (OAS) produces the linear oligonucleotide 2-5A, which binds to and activates RNase L to cleave host and viral RNA and activate RIG-I-like receptors. In <i>Immunity</i>, Yan and colleagues show that 2-5A is transferred from cell to cell through gap junctions to mediate short-range communication between cells during infection and cancer. RNase L-knockout A549 cells treated with poly(I:C) activate RNA cleavage in OAS-knockout A549 cells, whereas A549 cells expressing a constitutively active OAS induce IFN and ISG expression in wild-type but not in RNase L-knockdown mouse embryonic fibroblasts, both in a manner dependent on the connexins CX43 and CX45, which form gap junctions. Most cell types produce 2-5A after treatment with IFN or poly(I:C) and some also export it to the extracellular space. Extracellular 2-5A is imported in cells through the same transporters as the cyclic dinucleotide cGAMP. In culture, cells that can produce, export and import 2-5A have better control of VSV viral infection. In a model of MC38 cells implanted subcutaneously into C56BL/6 mice, MC38 cells that cannot make or export 2-5A or MC38 cells implanted in <i>Rnasel</i><sup>−/−</sup>, <i>Rag1</i><sup>−/−</sup> or <i>Ifnar1</i><sup>−/−</sup> mice grow faster than their wild-type counterparts. Expression of OAS correlates positively with the level of CD8<sup>+</sup> T cell infiltration and better survival in human cancer.</p><p><b>Original reference:</b> <i>Immunity</i> <b>58</b>, 797–810 (2025)</p>","PeriodicalId":19032,"journal":{"name":"Nature Immunology","volume":"15 1","pages":""},"PeriodicalIF":27.7000,"publicationDate":"2025-04-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Nature Immunology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1038/s41590-025-02157-z","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"IMMUNOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
The double-stranded RNA (dsRNA) sensor 2′,5′-oligoadenylate synthetase (OAS) produces the linear oligonucleotide 2-5A, which binds to and activates RNase L to cleave host and viral RNA and activate RIG-I-like receptors. In Immunity, Yan and colleagues show that 2-5A is transferred from cell to cell through gap junctions to mediate short-range communication between cells during infection and cancer. RNase L-knockout A549 cells treated with poly(I:C) activate RNA cleavage in OAS-knockout A549 cells, whereas A549 cells expressing a constitutively active OAS induce IFN and ISG expression in wild-type but not in RNase L-knockdown mouse embryonic fibroblasts, both in a manner dependent on the connexins CX43 and CX45, which form gap junctions. Most cell types produce 2-5A after treatment with IFN or poly(I:C) and some also export it to the extracellular space. Extracellular 2-5A is imported in cells through the same transporters as the cyclic dinucleotide cGAMP. In culture, cells that can produce, export and import 2-5A have better control of VSV viral infection. In a model of MC38 cells implanted subcutaneously into C56BL/6 mice, MC38 cells that cannot make or export 2-5A or MC38 cells implanted in Rnasel−/−, Rag1−/− or Ifnar1−/− mice grow faster than their wild-type counterparts. Expression of OAS correlates positively with the level of CD8+ T cell infiltration and better survival in human cancer.
期刊介绍:
Nature Immunology is a monthly journal that publishes the highest quality research in all areas of immunology. The editorial decisions are made by a team of full-time professional editors. The journal prioritizes work that provides translational and/or fundamental insight into the workings of the immune system. It covers a wide range of topics including innate immunity and inflammation, development, immune receptors, signaling and apoptosis, antigen presentation, gene regulation and recombination, cellular and systemic immunity, vaccines, immune tolerance, autoimmunity, tumor immunology, and microbial immunopathology. In addition to publishing significant original research, Nature Immunology also includes comments, News and Views, research highlights, matters arising from readers, and reviews of the literature. The journal serves as a major conduit of top-quality information for the immunology community.